LLY

NYSE

ELI LILLY & Co

Health Care, Pharmaceuticals

$1,185.71

close 7 Aug 2026

+86.66%

52-week change

$1.12T

market cap

$625.90

$1,249.45

52-week range

Expected price

$1,477.69 – $1,806.06

Current price

$1,185.71

Signal

Could be undervalued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)39.79x

P/S (TTM)14.01x

P/B32.95x

EV/EBITDA (TTM)32.52x

FCF yield (TTM)1.63%

PEG (TTM, GAAP)0.81

Context

P/E, own 5-year average67.71x

P/E, sector median29.65x*

Price at 5-year median P/E$1,618.21*

Indicated dividend yield0.58%

Forward — analyst consensus

Forward P/E (FY2026)32.75x*

Forward P/E (FY2027)25.68x

Forward PEG1.19*

Consensus EPS FY2026 (25 analysts)$36.21

EPS growth (FY2026→FY2027)27.52%

Revenue growth (FY2026)34.23%

Street view

Price target (mean)$1,297.31*

Target upside9.41%

Ratings (buy / hold / sell)22 / 4 / 2

FY2026 EPS revisions, 30d (up / down)0 / 19

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR +11.91%10Y CAGR +16.80%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$1,185.71

Cash & equivalents$8.95B

Total debt$54.91B

Shares outstanding941.36M

Result

DCF price per share$701.30

Current price$1,185.71

Margin of safety-40.85%

PV of years 1–10$222.35B

PV of terminal value$483.78B

Equity value$660.17B

Market-implied growth+18.40%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$20.36B	$22.78B	$25.49B	$28.53B	$31.93B	$35.73B	$39.99B	$44.75B	$50.08B	$56.04B	$1.04T
PV	$18.85B	$19.53B	$20.24B	$20.97B	$21.73B	$22.52B	$23.33B	$24.18B	$25.05B	$25.96B	$483.78B

period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026